High-Res Arrays Improve Cytogenetics Services as Field Shoots for 'Perfect Platform'
March 24, 2009
High-Res Arrays Improve Cytogenetics Services as Field Shoots for 'Perfect Platform'
In separate interviews, researchers at Baylor College of Medicine, Signature Genomic Laboratories, and the Children's Hospital of Philadelphia recently discussed how new arrays sold by Agilent, Affy, and Illumina affect their cytogenetics services.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Aussie Cytogeneticists Say Diagnostics 'Improved' After Switching to Array-Based Testing
February 24, 2009 / BioArray News - With NY License in Hand, Quest to Add Array-Based Cyto Testing for Prenatal, Oncology Apps
April 7, 2009 / BioArray News - Completing Platform Upgrade, Agilent Launches High-Density CGH and CNV Chips and Promises More
March 3, 2009 / BioArray News - Illumina Warns of 'Temporary' Slowdown in GWAS Growth Rate, Posts 36 Percent Rise in Q1 Sales
April 28, 2009 / BioArray News - Agilent Adds WTCCC-Designed CNV Chip to Menu to Target Association Studies
April 7, 2009 / BioArray News